Asensus Surgical Q1 Adj $(0.07) Misses $(0.05) Estimate, Sales $1.12M Miss $1.20M Estimate
Portfolio Pulse from Benzinga Newsdesk
Asensus Surgical (AMEX:ASXC) reported Q1 adjusted losses of $(0.07) per share, missing the $(0.05) estimate by 40%, and sales of $1.12M, missing the $1.20M estimate by 6.42%. Despite these misses, both losses and sales showed improvement over the previous year, with losses decreasing by 22.22% and sales increasing by 15.06%.
May 14, 2024 | 8:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Asensus Surgical reported a larger-than-expected Q1 loss and a slight miss in sales, but showed improvement over the previous year's figures.
The reported earnings miss and sales miss are likely to negatively impact investor sentiment in the short term, despite the year-over-year improvements. Typically, earnings misses can lead to a decrease in stock price as they may signal operational challenges or lower-than-expected growth. However, the improvement over the previous year's figures might mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100